A detailed history of Elkhorn Partners Limited Partnership transactions in Nephros Inc stock. As of the latest transaction made, Elkhorn Partners Limited Partnership holds 36,441 shares of NEPH stock, worth $56,483. This represents 0.04% of its overall portfolio holdings.

Number of Shares
36,441
Previous 36,000 1.23%
Holding current value
$56,483
Previous $76,000 18.42%
% of portfolio
0.04%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.71 - $2.29 $754 - $1,009
441 Added 1.23%
36,441 $62,000
Q1 2024

May 16, 2024

BUY
$2.11 - $3.78 $75,960 - $136,080
36,000 New
36,000 $79,000
Q4 2023

Feb 13, 2024

SELL
$1.46 - $3.91 $19,623 - $52,554
-13,441 Reduced 29.64%
31,900 $110,000
Q2 2023

Aug 14, 2023

SELL
$1.14 - $2.02 $5,699 - $10,100
-5,000 Reduced 9.93%
45,341 $70,000
Q3 2022

Nov 14, 2022

BUY
$0.91 - $1.87 $14,870 - $30,557
16,341 Added 48.06%
50,341 $46,000
Q2 2022

Aug 12, 2022

BUY
$1.47 - $4.63 $15,123 - $47,633
10,288 Added 43.39%
34,000 $52,000
Q1 2022

May 10, 2022

BUY
$3.89 - $6.12 $33,111 - $52,093
8,512 Added 56.0%
23,712 $104,000
Q4 2021

Feb 14, 2022

BUY
$5.87 - $8.46 $39,329 - $56,682
6,700 Added 78.82%
15,200 $90,000
Q2 2021

Aug 13, 2021

SELL
$6.61 - $10.68 $36,480 - $58,942
-5,519 Reduced 39.37%
8,500 $86,000
Q1 2021

May 11, 2021

SELL
$6.65 - $8.93 $1,802 - $2,420
-271 Reduced 1.9%
14,019 $93,000
Q4 2020

Feb 12, 2021

SELL
$5.86 - $8.58 $8,262 - $12,097
-1,410 Reduced 8.98%
14,290 $123,000
Q3 2020

Nov 16, 2020

BUY
$5.58 - $8.45 $15,305 - $23,178
2,743 Added 21.17%
15,700 $114,000
Q1 2020

May 13, 2020

BUY
$5.99 - $10.29 $42,223 - $72,534
7,049 Added 119.31%
12,957 $82,000
Q4 2019

Feb 14, 2020

BUY
$7.91 - $11.35 $46,732 - $67,055
5,908 New
5,908 $59,000

Others Institutions Holding NEPH

About NEPHROS INC


  • Ticker NEPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 10,318,800
  • Market Cap $16M
  • Description
  • Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...
More about NEPH
Track This Portfolio

Track Elkhorn Partners Limited Partnership Portfolio

Follow Elkhorn Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elkhorn Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Elkhorn Partners Limited Partnership with notifications on news.